Last inclusion of a patient in METAglut1 validation study
juin 21, 2021
March. 31st 2021 – Last inclusion of a patient in METAglut1 validation study
The METAglut1 study is a prospective study to validate the diagnostic performance of METAglut1 test. It was conducted in 32 French centers. More than 650 patients have been included over a period of 31 months. This study benefits from a Forfait Innovation granted by the French DGOS and HAS.
We target cell metabolism
Pépinière Paris Biotech Santé 29 rue du Faubourg Saint Jacques, 75014 Paris, France Phone: +33 9 61 62 65 17 email@example.com
METAFORA biosystems, Inc. 100 South State Street Chicago, IL 60603 Suite 417